oxalate, a metabolite of an anti cancer drug oxaliplatin, has been demonstrated to inhibit prolyl hydroxylase, which endows cold-insensitive human trpa1 with pseudo cold sensitivity (via reactive oxygen generation from mitochondria). this may cause a characteristic side-effect of oxaliplatin (cold-triggered acute peripheral neuropathy).